Answers are grounded in this paper and cite their sources.
This review revisits alpha‑fetoprotein (AFP) and AFP receptor biology beyond their classic role as oncofetal markers. It summarizes signaling, tumor biology, and clinical implications across malignancies, including diagnostic, prognostic, and therapeutic angles. The authors highlight opportunities and limitations for AFP‑targeted interventions. Academic Editor: Qingwen Xu, Checked for plagiarism: Yes Review by: Single-blind Copyright © 2019 Vladimir N Pak, et al. License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Corresponding author: Corresponding author: Vladimir N. Pak, Research Scientist, Toronto, Ontario, Canada — The authors have declared that no competing interests exist. No specific funding statement was provided by the authors. No data-availability statement was provided by the authors. Citation: Download as RIS , BibTeX , EndNote , Text (Include abstract )
No takes yet. Share an insight, caveat, or question.
Vladimir N Pak (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: